Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) and...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RumbleON, Inc. (“RumbleON” or the “Company”) (NASDAQ: RMBL). Such investors are advised to...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP; NRXPW) and...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (NYSE: SLI) and...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR). Such investors are...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP notifies investors of eHealth, Inc. (NASDAQ: EHTH) (“eHealth” or the “Company”) of a pending lawsuit against eHealth and certain of its...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). Such investors...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH). Such investors are...
-
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FirstCash, Inc. (“FirstCash” or the “Company”) (NASDAQ: FCFS). Such investors are advised...